Accession Number: | 0001209191-21-042000 |
Date: | 2021-06-16 |
Issuer: | ADICET BIO, INC. (ACET) |
Original Submission Date: |
SCHOR CHEN
C/O ADICET BIO, INC.
500 BOYLSTON STREET, 13TH FLOOR
BOSTON, MA 02116
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-06-16 | S | 7,484 | d | $10.53 | 74,841 | indirect | f3 | |
COMMON STOCK | 2021-06-16 | S | 8,982 | d | $10.53 | 89,836 | indirect | f4 |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person. |
f2 | the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions in prices ranging from $10.32 to $10.86, inclusive. |
f3 | represents shares held directly by an irrevocable family trust having an independent trustee. |
f4 | represents shares held directly by an irrevocable family trust having an independent trustee. |